These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 20667741)
1. Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors. Reddy NP; Aparoy P; Reddy TC; Achari C; Sridhar PR; Reddanna P Bioorg Med Chem; 2010 Aug; 18(16):5807-15. PubMed ID: 20667741 [TBL] [Abstract][Full Text] [Related]
2. Structure based drug design, synthesis and evaluation of 4-(benzyloxy)-1-phenylbut-2-yn-1-ol derivatives as 5-lipoxygenase inhibitors. Reddy NP; Chandramohan Reddy T; Aparoy P; Achari C; Sridhar PR; Reddanna P Eur J Med Chem; 2012 Jan; 47(1):351-9. PubMed ID: 22118829 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents. Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases. Rao PN; Chen QH; Knaus EE J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583 [TBL] [Abstract][Full Text] [Related]
5. Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase. Shaari K; Suppaiah V; Wai LK; Stanslas J; Tejo BA; Israf DA; Abas F; Ismail IS; Shuaib NH; Zareen S; Lajis NH Bioorg Med Chem; 2011 Nov; 19(21):6340-7. PubMed ID: 21958738 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292 [TBL] [Abstract][Full Text] [Related]
7. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase. Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors. Song H; Oh SR; Lee HK; Han G; Kim JH; Chang HW; Doh KE; Rhee HK; Choo HY Bioorg Med Chem; 2010 Nov; 18(21):7580-5. PubMed ID: 20870413 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371 [TBL] [Abstract][Full Text] [Related]
10. Antiproliferative activity of chalcones with basic functionalities. Liu X; Go ML Bioorg Med Chem; 2007 Nov; 15(22):7021-34. PubMed ID: 17804245 [TBL] [Abstract][Full Text] [Related]
11. Simple chalcones and bis-chalcones ethers as possible pleiotropic agents. Liargkova T; Hadjipavlou-Litina DJ; Koukoulitsa C; Voulgari E; Avgoustakis C J Enzyme Inhib Med Chem; 2016; 31(2):302-13. PubMed ID: 25798685 [TBL] [Abstract][Full Text] [Related]
12. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase. Araico A; Terencio MC; Alcaraz MJ; Domínguez JN; León C; Ferrándiz ML Life Sci; 2006 May; 78(25):2911-8. PubMed ID: 16360707 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and SAR studies of 4-allyoxyaniline amides as potent 15-lipoxygensae inhibitors. Seyedi SM; Eshghi H; Jafari Z; Attaran N; Sadeghian H; Saberi MR; Riazi MM Bioorg Med Chem; 2009 Feb; 17(4):1614-22. PubMed ID: 19157886 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity. Bandgar BP; Patil SA; Korbad BL; Nile SH; Khobragade CN Eur J Med Chem; 2010 Jun; 45(6):2629-33. PubMed ID: 20171758 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents. Dong X; Chen J; Jiang C; Liu T; Hu Y Arch Pharm (Weinheim); 2009 Jul; 342(7):428-32. PubMed ID: 19544479 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity. Narender T; Khaliq T; Shweta ; Nishi ; Goyal N; Gupta S Bioorg Med Chem; 2005 Dec; 13(23):6543-50. PubMed ID: 16185885 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents. Özadalı K; Özkanlı F; Jain S; Rao PP; Velázquez-Martínez CA Bioorg Med Chem; 2012 May; 20(9):2912-22. PubMed ID: 22475926 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors. Lai Y; Ma L; Huang W; Yu X; Zhang Y; Ji H; Tian J Bioorg Med Chem Lett; 2010 Dec; 20(24):7349-53. PubMed ID: 21055929 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation. Rao YK; Fang SH; Tzeng YM Bioorg Med Chem; 2009 Dec; 17(23):7909-14. PubMed ID: 19875299 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors. Suh J; Yum EK; Cheon HG; Cho YS Chem Biol Drug Des; 2012 Jul; 80(1):89-98. PubMed ID: 22404847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]